EMA Says No To Extending Clock-Stops For Immature Marketing Applications
Companies Should Ensure Dossiers Are As Mature As Possible From Day One
The European Medicines Agency wants to discourage drug companies from submitting marketing applications with very interim data cuts and then expecting they can supplement their application with more data later on by requesting for extended clock-stops.
